Braster

What Braster does

Braster S.A. is a publicly listed Polish medical technology company (WSE: BRS, IPO June 2015) that develops and commercializes liquid crystal contact thermography (CLCF) devices for breast health screening. Its portfolio comprises the Braster System, a consumer device sold direct-to-consumer in Poland and the Netherlands at 1,799-2,798 PLN (390-600 EUR), and Braster Pro, a professional unit sold to gynecologists and clinics at ~2,799-2,999 PLN; the company operates an 80+ certified Pro clinic network in Poland. Thermographic images captured by the devices are uploaded via the Braster Care mobile app to a telemedical center where AI algorithms (co-developed with Warsaw University of Technology and supported by an EU grant of ~5.1M PLN) perform two-method asymmetry and longitudinal differential analysis, with results returned in approximately two working days.

The company monetizes through a mix of one-time device hardware sales (System, Pro, replacement matrix sets), recurring examination credit packages (6/12/24/50/100 credits valid 7-26 months), accessories, and B2B distribution via national partners in markets including Hungary, Ukraine, the UK, Bulgaria, Korea, and the Balkans, plus corporate wellness deployments such as Santander Consumer Bank. Braster is CE-marked (Council Directive 93/42/EEC), ISO 13485 and ISO 9001 certified (TÜV NORD), and has formal recognition from the Polish Society of Gynecologists and Obstetricians as a complementary examination to mammography or ultrasound.

Clinically, Braster cites 81.5% sensitivity and 87% specificity in women under 50 (TheraALG study), 82% efficacy detecting changes smaller than 2 cm, and a detection threshold from 3 mm, supported by observational studies across more than 4,600 women in collaboration with Collegium Medicum of Jagiellonian University, Military Institute of Medicine, and other Polish oncology centers. R&D, manufacturing partnerships (Creotech, ROSTI Sweden, Pezy Netherlands), and product marketing are coordinated from its headquarters in Ożarów Mazowiecki, Poland, with the underlying technology protected as proprietary inventions and brand identity.

Name

Braster

Legal name

BRASTER S.A.

Website

https://braster.eu

Company type

Public

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

Braster S.A. is a Polish publicly traded MedTech (WSE: BRS) that builds liquid crystal contact thermography devices — the consumer Braster System and the clinical Braster Pro — paired with AI-driven telemedical analysis for early breast cancer screening, sold direct-to-consumer and through certified clinics across more than 22 international markets.

Ownership category

akta.pro rank

Product category

Medical Devices for Breast Cancer Screening

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Medical Equipment and Supplies Manufacturing (3391)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHABAF

Mammography & Breast Imaging Systems

Healthcare & Life Sciences/Medical Devices & Diagnostics/Medical Imaging & Radiology Equipment

SECONDARYHLAHACAK

Continuous Temperature & Fever Monitoring (Wearable Thermometry)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Patient Monitoring, Wearables & Remote Diagnostics

SECONDARYCRACAQAJ

Women’s Health & Fertility Tracking Devices (Ovulation/Temp Sensors, Pelvic Health Devices)

Consumer Products & Retail/Consumer Electronics & Appliances Retail/Personal Health & Wellness Devices (Smart Scales, BP/ECG Monitors, Sleep Devices)

Keywords

• Contact thermography devices
• Breast cancer screening
• Medical imaging technology
• Home diagnostic devices
• Telemedicine screening

Headquarters

HQ city

Ozarow Mazowiecki

HQ country

Poland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Medical Device Sales (Braster System): One-time sale of the Braster medical device for home breast examination. Includes device hardware, 3 matrices, and initial examination package. Purchased directly through e-commerce store.
2. Examination Packages: Recurring revenue from examination package subscriptions. Customers purchase examination credits (6, 12, 24, 50, or 100 exams) that expire within specified periods (7-26 months). Includes access to Braster Care app and telemedical analysis.
3. Braster Pro Professional Device Sales: Sale of Braster Pro medical devices to healthcare professionals and clinics, including device, matrices, and initial examination package. Targeted at gynecological and medical offices.
4. Accessories and Replacement Matrices: Sale of replacement matrix sets (3 matrices per set) and other accessories. Matrices have approximately 3-year lifespan and require replacement.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels9 records

Core offering

Braster develops and sells medical devices for breast cancer screening based on proprietary liquid crystal contact thermography technology. The portfolio includes the Braster System for at-home monthly self-examination, the Braster Pro for use by healthcare professionals in clinical settings, and a Temperature Indicator for fever screening. Each device is paired with the Braster Care mobile app and remote AI-powered telemedical analysis that delivers examination results within 2 working days.

Product overview

Braster offers a portfolio of breast health monitoring products centered on liquid crystal contact thermography technology. The core offerings include Braster System for home use and Braster Pro for professional clinical settings, both utilizing proprietary AI-powered algorithms to detect thermal and structural asymmetries in breast tissue. Braster System is a consumer-facing product combining a handheld medical device, the Braster Care smartphone app, and telemedical center analysis services for monthly self-examinations. Braster Pro adapts this technology for healthcare professionals in medical clinics. Additional products include examination credit packages, replacement matrix sets, and the Temperature Indicator for general fever screening.

Differentiator

Problem solved

Functional benefit

Brands

• Braster System: In-home breast examination system using contact thermography with telemedicine support for monthly self-examinations
• Braster Pro

Products and services

• Braster System In-home breast examination system for individual women. Includes the Braster handheld medical device (wireless, portable, radiation-free), a set of 3 liquid crystal matrices, the Braster Care mobile app, and AI-powered telemedical analysis delivered within 2 working days for monthly self-examination.
• Braster Pro Professional breast examination system for healthcare professionals (gynecologists, oncologists, clinics). Uses the same liquid crystal contact thermography technology with AI-powered automated interpretation to support early breast cancer diagnosis during standard patient visits.
• Braster Start Consumer bundle of the Braster System — the Braster medical device plus a set of 3 liquid crystal matrices and 4 free examination credits usable within 7 months of activation. Targeted at individual first-time users.
• Braster Duo Braster system package for two users sharing a single device — includes the Braster device, an extra set of 3 matrices, and two packages of 3 examination credits each, with separate user accounts.
• Temperature Indicator Self-adhesive thermosensitive foil device applied to the forehead for non-contact fever screening, using Braster's liquid crystal technology. Targeted at medical staff, care-facility patients, and office or factory employee screening.
• Examination Packages Recurring examination credit packages available in 6, 12, 24, 50, and 100 examination sizes with validity periods ranging from 7 to 26 months from activation. Each credit enables one breast thermography examination analyzed by the Brasster Telemedical Center, with access to the Braster Care app.
• Set of 3 Replacement Matrices Replacement liquid crystal matrix set (3 matrices per set) for the Braster device. Each matrix has different thermal sensitivity ranges matched to different breast temperature ranges; matrices have a lifespan of approximately 3 years and must be replaced thereafter.

Quantifiable outcome

• 81.5% sensitivity and 87% specificity in women under 50 (ThermaALG study)
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature5 records

Partnerships

Nine partnerships are on record, tiered minor and core.

• Hungarian DistributorminorChannel Partner/ Reseller/ Distributor · 1 July 2018Distribution agreement for Hungarian market as part of international expansion strategy.
• Ukrainian DistributorminorChannel Partner/ Reseller/ Distributor · 1 July 2018Distribution agreement for Ukrainian market as part of international expansion strategy.
• Santander Consumer BankminorGTM or Marketing Partner · 1 December 2017Corporate wellness partnership where Santander Consumer Bank employees can check their breast health monthly using Braster System as part of employee health benefits program.
• ROSTI (Sweden)coreTechnology or Integration · 1 March 2016Swedish manufacturing partner for production of Braster medical devices. Partnership established to launch manufacturing of the medical device for commercial distribution.
• Pezy (Netherlands)coreTechnology or Integration · 1 December 2015Dutch design partner that helped prepare the consumer version of the Braster device for market launch. Collaboration on product design and user experience.
• CreotechcoreTechnology or Integration · 1 March 2015Manufacturing partnership for new generation thermographic image registering heads used in observational clinical studies. Creotech manufactures specialized equipment for Braster's research and development activities.
• Warsaw University of TechnologycoreStrategic or Co-development PartnerAcademic partnership for development of automatic interpretation system for thermographic images and differential analysis algorithms. Joint research on optimizing AI systems for breast cancer detection.
• Maiczin Dom Hospital (Sofia, Bulgaria)coreChannel Partner/ Reseller/ DistributorDesignated as BRASTER Reference Center for Balkan countries. Hospital serves as hub for Braster Pro distribution and training in the region.
• Innomed Research NetworkcoreStrategic or Co-development PartnerMulticenter observational study involving approximately 3000 women conducted by Collegium Medicum of Jagiellonian University in cooperation with multiple oncology centers across Poland.

Scale indicators9 records

Recent moves7 records

Expansion highlights5 records

Broad incumbents

• Hologic: Global leader in mammography and breast health imaging (3Dimensions, Genius AI CAD). Comparable as a dominant breast-cancer screening device manufacturer; Braster is the smaller, complementary thermography entrant addressing intervals between Hologic's core mammography exams.
• Siemens Healthineers: Major breast imaging player (MAMMOMAT tomosynthesis, AI-Rad Companion). Comparable as a large incumbent in clinical breast cancer detection whose installed mammography base defines the screening workflow Braster plugs into between visits.
• GE HealthCare: Mammography and women's health imaging provider (Pristina, Invenia ABUS). Comparable as a broad clinical incumbent whose screening platform competes with — and channels patients toward — Braster's complementary monitoring device.
• Philips Healthcare: Wide-portfolio women's health and patient monitoring vendor (MicroDose mammography). Comparable as a multi-modality incumbent whose clinical scale and channel relationships Braster must navigate to win clinic placements.
• Samsung Medison (Samsung Healthcare): Women's imaging/ultrasound vendor with growing breast imaging product line. Comparable as a broad imaging incumbent whose handheld/portable ultrasound strategy parallels Braster's positioning of portable, clinic-friendly diagnostic tools.

Emerging players

• iCAD, Inc. AI-based breast cancer detection and risk prediction vendor (ProFound AI). Comparable as a breast-AI software-focused company; Braster pairs analogous AI interpretation with a thermal-imaging sensor, making both complementary rather than direct competitors.
• Volpara Health Technologies: AI-based breast density and risk assessment platform. Comparable as a specialized breast-imaging analytics company serving clinics and consumers; Braster competes for clinical mindshare around adjunctive breast screening.
• ScreenPoint Medical: Developer of AI for mammography (Transpara). Comparable as a software-led breast imaging AI peer building decision-support tools that clinicians layer onto screening workflows, similar to Braster's Telemedical AI analysis.

Direct peers

• Realtherm / Infrared Sciences Corp: Specialist in infrared/thermal breast imaging for clinical screening. Comparable as a direct thermography-based breast screening peer addressing the same niche market position Braster occupies.

Regional players

• Thermography.com / Med-Hot Thermal Imaging: US-based clinical thermal imaging service providers that perform breast thermography screening in clinical settings. Comparable as breast-thermography service providers operating in adjacent geographies, illustrating the regional competitive set Braster must differentiate against in-market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Braster.eu

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Braster